BANK OF MONTREAL /CAN/ - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$2,908,000
-51.9%
682,365
-35.2%
0.00%
-50.0%
Q4 2020$6,048,000
+40.3%
1,053,683
+41.5%
0.00%0.0%
Q3 2020$4,312,000
+53800.0%
744,887
+24729.6%
0.00%
Q2 2020$8,000
-66.7%
3,000
-11.4%
0.00%
Q4 2019$24,000
+4.3%
3,385
+45.0%
0.00%
Q3 2019$23,000
-11.5%
2,335
+4.1%
0.00%
Q2 2019$26,000
+1200.0%
2,242
+2285.1%
0.00%
Q4 2018$2,000
+100.0%
94
+104.3%
0.00%
Q3 2018$1,000460.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders